Effects of lumacaftor-ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2-11 years

Rationale: Lumacaftor/ivacaftor was approved for the treatment of patients with cystic fibrosis who are homozygous for F508del aged 2 years and older following positive results from phase three trials. However, the improvement in CFTR function associated with lumacaftor/ivacaftor has only been studi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Julian Berges (Auteur), Simon Y. Graeber (Auteur), Susanne Hämmerling (Auteur), Yin Yu (Auteur), Arne Krümpelmann (Auteur), Mirjam Stahl (Auteur), Stephanie Hirtz (Auteur), Heike Scheuermann (Auteur), Marcus A. Mall (Auteur), Olaf Sommerburg (Auteur)
Formaat: Boek
Gepubliceerd in: Frontiers Media S.A., 2023-05-01T00:00:00Z.
Onderwerpen:
Online toegang:Connect to this object online.
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

Connect to this object online.

3rd Floor Main Library

Exemplaargegevens van 3rd Floor Main Library
Plaatsingsnummer: A1234.567
Kopie 1 Beschikbaar